Literature DB >> 27486245

Intratumoral oxygen gradients mediate sarcoma cell invasion.

Daniel M Lewis1, Kyung Min Park1, Vitor Tang1, Yu Xu1, Koreana Pak2, T S Karin Eisinger-Mathason2, M Celeste Simon3, Sharon Gerecht4.   

Abstract

Hypoxia is a critical factor in the progression and metastasis of many cancers, including soft tissue sarcomas. Frequently, oxygen (O2) gradients develop in tumors as they grow beyond their vascular supply, leading to heterogeneous areas of O2 depletion. Here, we report the impact of hypoxic O2 gradients on sarcoma cell invasion and migration. O2 gradient measurements showed that large sarcoma mouse tumors (>300 mm(3)) contain a severely hypoxic core [≤0.1% partial pressure of O2 (pO2)] whereas smaller tumors possessed hypoxic gradients throughout the tumor mass (0.1-6% pO2). To analyze tumor invasion, we used O2-controllable hydrogels to recreate the physiopathological O2 levels in vitro. Small tumor grafts encapsulated in the hydrogels revealed increased invasion that was both faster and extended over a longer distance in the hypoxic hydrogels compared with nonhypoxic hydrogels. To model the effect of the O2 gradient accurately, we examined individual sarcoma cells embedded in the O2-controllable hydrogel. We observed that hypoxic gradients guide sarcoma cell motility and matrix remodeling through hypoxia-inducible factor-1α (HIF-1α) activation. We further found that in the hypoxic gradient, individual cells migrate more quickly, across longer distances, and in the direction of increasing O2 tension. Treatment with minoxidil, an inhibitor of hypoxia-induced sarcoma metastasis, abrogated cell migration and matrix remodeling in the hypoxic gradient. Overall, we show that O2 acts as a 3D physicotactic agent during sarcoma tumor invasion and propose the O2-controllable hydrogels as a predictive system to study early stages of the metastatic process and therapeutic targets.

Entities:  

Keywords:  gradients; hydrogel; hypoxia; migration; sarcoma

Mesh:

Substances:

Year:  2016        PMID: 27486245      PMCID: PMC4995943          DOI: 10.1073/pnas.1605317113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  A spatially and temporally restricted mouse model of soft tissue sarcoma.

Authors:  David G Kirsch; Daniela M Dinulescu; John B Miller; Jan Grimm; Philip M Santiago; Nathan P Young; G Petur Nielsen; Bradley J Quade; Christopher J Chaber; Christian P Schultz; Osamu Takeuchi; Roderick T Bronson; Denise Crowley; Stanley J Korsmeyer; Sam S Yoon; Francis J Hornicek; Ralph Weissleder; Tyler Jacks
Journal:  Nat Med       Date:  2007-08-05       Impact factor: 53.440

2.  Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis.

Authors:  Muhammad H Zaman; Linda M Trapani; Alisha L Sieminski; Alisha Siemeski; Drew Mackellar; Haiyan Gong; Roger D Kamm; Alan Wells; Douglas A Lauffenburger; Paul Matsudaira
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma.

Authors:  Nabil Wasif; Robert M Tamurian; Scott Christensen; Ly Do; Steve R Martinez; Steven L Chen; Robert J Canter
Journal:  Ann Surg Oncol       Date:  2011-07-16       Impact factor: 5.344

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis.

Authors:  Amal M El-Naggar; Chansey J Veinotte; Hongwei Cheng; Thomas G P Grunewald; Gian Luca Negri; Syam Prakash Somasekharan; Dale P Corkery; Franck Tirode; Joan Mathers; Debjit Khan; Alastair H Kyle; Jennifer H Baker; Nancy E LePard; Steven McKinney; Shamil Hajee; Momir Bosiljcic; Gabriel Leprivier; Cristina E Tognon; Andrew I Minchinton; Kevin L Bennewith; Olivier Delattre; Yuzhuo Wang; Graham Dellaire; Jason N Berman; Poul H Sorensen
Journal:  Cancer Cell       Date:  2015-05-11       Impact factor: 31.743

7.  Trends in survival for patients with metastatic soft-tissue sarcoma.

Authors:  Antoine Italiano; Simone Mathoulin-Pelissier; Axel Le Cesne; Philippe Terrier; Sylvie Bonvalot; Françoise Collin; Jean-Jacques Michels; Jean-Yves Blay; Jean-Michel Coindre; Binh Bui
Journal:  Cancer       Date:  2010-10-13       Impact factor: 6.860

Review 8.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

9.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

Review 10.  Hypoxia and the extracellular matrix: drivers of tumour metastasis.

Authors:  Daniele M Gilkes; Gregg L Semenza; Denis Wirtz
Journal:  Nat Rev Cancer       Date:  2014-05-15       Impact factor: 60.716

View more
  41 in total

Review 1.  Developing Cures: Targeting Ontogenesis in Cancer.

Authors:  Victor T G Lin; Hawley C Pruitt; Rajeev S Samant; Lalita A Shevde
Journal:  Trends Cancer       Date:  2017-01-27

2.  TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).

Authors:  Shuai Ye; Ying Liu; Ashley M Fuller; Rohan Katti; Gabrielle E Ciotti; Susan Chor; Md Zahidul Alam; Samir Devalaraja; Kristin Lorent; Kristy Weber; Malay Haldar; Michael A Pack; T S Karin Eisinger-Mathason
Journal:  Mol Cancer Res       Date:  2020-01-27       Impact factor: 5.852

3.  Functionally graded biomaterials for use as model systems and replacement tissues.

Authors:  Jeremy M Lowen; J Kent Leach
Journal:  Adv Funct Mater       Date:  2020-03-04       Impact factor: 18.808

Review 4.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

5.  Gradient Hydrogels.

Authors:  Antonina Lavrentieva
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 6.  Immunometabolism in early and late stages of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Rev Rheumatol       Date:  2017-03-31       Impact factor: 20.543

7.  Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.

Authors:  Eric R Molina; Letitia K Chim; Sergio Barrios; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2020-02-14       Impact factor: 6.389

Review 8.  Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment.

Authors:  Chien-Chi Lin; Murray Korc
Journal:  Cancer Lett       Date:  2018-08-14       Impact factor: 8.679

9.  O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo.

Authors:  Daniel M Lewis; Michael R Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  Nat Protoc       Date:  2017-07-20       Impact factor: 13.491

Review 10.  The Different Routes to Metastasis via Hypoxia-Regulated Programs.

Authors:  Ana Rita Nobre; David Entenberg; Yarong Wang; John Condeelis; Julio A Aguirre-Ghiso
Journal:  Trends Cell Biol       Date:  2018-07-23       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.